The archive
137 stories from 60 issues. Filter by industry, type of news, date or company, and choose how much to read.
Type of news
Industry
Company
1 story
- 21 OctNew
Funding
OpenAI buys Orchestra Bio to bring AI into drug development workWhy it matters Biopharma teams now have OpenAI heading into their R&D operations, so reassess any AI workflow vendors you rely on.
Impact Drug developers gain OpenAI-run AI for R&D operations, competing with existing workflow vendors.
What happened OpenAI is buying Orchestra Bio, a company that applies AI to the day-to-day running of research and development in the life sciences. The aim is to help drug makers move treatments through development faster.